Stay updated on Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page history shows the revision tag updated from v3.5.3 to v3.5.4, indicating a platform release rather than a change to the study data.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing the previous v3.5.2. This indicates the study history record has been updated to a newer version.SummaryDifference0.0%

- Check39 days agoChange DetectedFooter Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.0%

- Check75 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous v3.4.2 entry was removed.SummaryDifference0.0%

- Check104 days agoChange DetectedAdded Revision: v3.4.2 to the history. Removed notices about government funding lapse and NIH Clinical Center operating status (Revision: v3.4.1).SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.